Bionomics Limited - American De (BNOX) Financials

BNOX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 27.6 million 6.3 million
2023-06-30 28.5 million 6.5 million
2023-03-31 11.0 million 1.4 million
2022-12-31 38.4 million 5.8 million

BNOX Free Cash Flow and Stock based compensation

No data available :(

BNOX Net Income

No data available :(

BNOX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 11.7 million - -
2023-06-30 12.1 million - 353994
2023-03-31 5.6 million - -
2022-12-31 20.9 million - 418615

BNOX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 5.2 million
2023-06-30 974.4 million
2023-03-31 5.9 million
2022-12-31 5.6 million

BNOX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 3.8 million 1.5 million 35094
2023-06-30 - - - -
2023-03-31 106101 3.0 million 1.5 million 36641
2022-12-31 - 4.9 million 1.9 million -

BNOX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 9573 2.8 million
2023-06-30 - -
2023-03-31 173425 3.0 million
2022-12-31 44895 -

BNOX

Price: $1

52 week price:
0.87
6.41

Earnings Per Share: -2.37 USD

P/E Ratio: -0.38

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 1400

Market Capitalization: 11.0 million

Links: